Chardan Capital Sticks to Their Buy Rating for Solid Biosciences Llc

Chardan Capital analyst Gbola Amusa maintained a Buy rating on Solid Biosciences Llc (NASDAQ: SLDB) today and set a price target of $60. The company’s shares closed on Friday at $42.07. Amusa More »

B.Riley FBR Initiates a Buy Rating on Wideopenwest Inc

In a report issued on June 21, Zachary Silver from B.Riley FBR initiated coverage with a Buy rating on Wideopenwest Inc (NYSE: WOW) and a price target of $14. The company’s shares More »